𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Production and disposition of 1-methyl-4-phenylpyridinium in primary cultures of mouse astrocytes

✍ Scribed by Dr. Donato A. Di Monte; Ellen Y. Wu; Ian Irwin; Louis E. Delanney; J. William Langston


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
805 KB
Volume
5
Category
Article
ISSN
0894-1491

No coin nor oath required. For personal study only.

✦ Synopsis


Dopaminergic neurons are a primary target for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. However, the conversion of MPTP to its neurotoxic 1-methyl-4-phenylpyridinium metabolite (MPP+ ) is likely to occur in astrocytes via the monoamine oxidase (MA0)-dependent formation of the 1-methyl-4-phenyl-2,3-dihydropyridinium intermediate (MPDP+). The main purpose of this study was to characterize the molecular mechanism(s1 by which MPP+ , once generated by astrocytes, may reach the extracellular space to become available for the active accumulation into dopaminergic neurons. Primary cultures of mouse astrocytes were used as an in vitro model system. After the addition of MPTP, levels of MPP+ were found to increase at constant rates both intracellularly and extracellularly at time points when no sign of cytotoxicity was evident. In contrast, MPDP+ levels remained quite stable during 4 days of incubation in the presence of MPTP. Finally, when astrocytes were allowed to accumulate MPP+ by pretreatment with either MPTP or MPP+ and then were incubated in fresh medium not containing MPTP or MPP+, intracellular levels of MPP+ rapidly declined and corresponding amounts of this compound were found in the incubation medium. Results of this study are compatible with the following conclusions: 1) the MPP+ accumulated in the extracellular compartment during incubations with MPTP is not released from astrocytes as a consequence of its own cytotoxic effects; 2) MPP+ can be formed extracellularly presumably via autoxidation of MPDP+ after this latter compound has been generated within astrocytes and has crossed astrocyte membranes; and 3) despite its charged chemical structure, MPP+ can cross the plasma membrane toward the extracellular space after being formed within astrocytes.

01992 Wiley-Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Differences in the disposition and toxic
✍ May J. Tsai; Dr. Eminy H. Y. Lee πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 735 KB

Species difference in the susceptibility to l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) was investigated in cultured rat and mouse astrocytes, where 1-methyl-4-phenylpyridinium (MPP+), the toxic mediator of MPTP, is formed. Type A monoamine oxidase (MAO) predominated in both rat and mouse as

Ammonia-induced production of free radic
✍ C.R.K. Murthy; K.V. Rama Rao; Ge Bai; Michael D. Norenberg πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract Elevated levels of ammonia in blood and brain result in derangement of cerebral function. Recently, lipid peroxidation and oxidative stress have been implicated in ammonia neurotoxicity. Because ammonia is primarily detoxified in astrocytes, we postulated that pathophysiological concent

Dynamic morphological responses of mouse
✍ Dr. Richard M. Devon; Bernhard H.J. Juurlink πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 819 KB

Within 5 minutes of changing the medium of 3 4 week old mouse astrocyte cultures, dramatic morphological alterations were seen in the cultures at the phase microscope level. These alterations included the appearance of membrane ruffles, followed by the formation of phase light vacuolar regions. Ultr

In vivo protection of striatal dopaminer
✍ MarΓ­a Luisa Vizuete; Miguel Merino; Josefina Cano; Alberto Machado πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 180 KB πŸ‘ 1 views

We have studied the effect of a semichronic and acute treatment of phenobarbital on in vivo 1-methyl-4-phenylpyridinium ion- (MPP+)-induced neurotoxicity. A group of rats were intraperitoneally injected for 12 days with phenobarbital (80 mg/Kg of body weight, semichronic treatment) in order to induc